International Stem Cell (ISCO) Receivables (2010 - 2026)
International Stem Cell's (ISCO) quarterly Receivables came in at $959000.0 in Q2 2026, down 12.9% year-over-year from $1.1 million in Q2 2025, and up 32.64% quarter-over-quarter from $723000.0 in Q4 2025.
Powered by 
Analysis
International Stem Cell (ISCO) Receivables (2010 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Receivables for 17 consecutive years, with $959000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Receivables fell 12.9% year-over-year to $959000.0 in Q2 2026; TTM through Jun 2026 was $959000.0, a 12.9% decrease from a year earlier, with the FY2025 full-year figure at $723000.0, down 31.66% from the prior year.
- Receivables was $959000.0 for Q2 2026 at International Stem Cell, up from $723000.0 in the prior quarter.
- Over five years, Receivables peaked at $1.1 million in Q2 2025 and troughed at $427000.0 in Q3 2022.
- A 5-year average of $772705.9 and a median of $723000.0 in 2025 frame the typical range for Receivables.
- The widest YoY moves for Receivables: up 106.41% in 2022, down 36.08% in 2022.
- Over 5 years, Receivables stood at $747000.0 in 2022, then slipped by 23.16% to $574000.0 in 2023, then surged by 84.32% to $1.1 million in 2024, then sank by 31.66% to $723000.0 in 2025, then soared by 32.64% to $959000.0 in 2026.
- The last three Receivables figures came in at $959000.0 (Q2 2026), $723000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 138.70 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | 102.12 Mn |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | 5.78 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 72.04 Mn |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.40 Bn | 251.87 Mn | 421.82 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | 75.71 Mn |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn | 959,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 959,000.00 |
| Dec 31, 2025 | 723,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 851,000.00 |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 680,000.00 |
| Jun 30, 2024 | 810,000.00 |
| Mar 31, 2024 | 632,000.00 |
| Dec 31, 2023 | 574,000.00 |
| Sep 30, 2023 | 644,000.00 |
| Jun 30, 2023 | 662,000.00 |
| Mar 31, 2023 | 688,000.00 |
| Dec 31, 2022 | 747,000.00 |
| Sep 30, 2022 | 427,000.00 |
| Jun 30, 2022 | 663,000.00 |
| Mar 31, 2022 | 902,000.00 |
| Dec 31, 2021 | 844,000.00 |
| Sep 30, 2021 | 668,000.00 |
| Jun 30, 2021 | 547,000.00 |